share_log

Piper Sandler Downgrades Galera Therapeutics to Neutral, Lowers Price Target to $0.5

Benzinga ·  Aug 10, 2023 05:35

Piper Sandler analyst Edward Tenthoff downgrades Galera Therapeutics (NASDAQ:GRTX) from Overweight to Neutral and lowers the price target from $6 to $0.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment